Insulin, fat, and bone: multiple interactions lead to complex biology.
作者信息
Blank Robert D
机构信息
Department of Medicine, University of Wisconsin, Madison, WI 53705, USA.
出版信息
Transl Res. 2013 Mar;161(3):141-4. doi: 10.1016/j.trsl.2012.10.009. Epub 2012 Nov 21.
Abstract
摘要
相似文献
1
Insulin, fat, and bone: multiple interactions lead to complex biology.
Transl Res. 2013 Mar;161(3):141-4. doi: 10.1016/j.trsl.2012.10.009. Epub 2012 Nov 21.
2
The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes.
Transl Res. 2013 Mar;161(3):145-55. doi: 10.1016/j.trsl.2012.08.006. Epub 2012 Sep 27.
3
Thiazolidinediones.
N Engl J Med. 2005 Jan 13;352(2):205-7; author reply 205-7.
4
Type 2 diabetes, thiazolidinediones: bad to the bone?
J Clin Endocrinol Metab. 2006 Sep;91(9):3276-8. doi: 10.1210/jc.2006-1235.
5
[Thiazolidinediones and skeletal health].
Rev Med Suisse. 2009 Jun 10;5(207):1309-10, 1312-3.
6
Skeletal toxicity of thiazolidinediones.
Ann Intern Med. 2008 Apr 1;148(7):563. doi: 10.7326/0003-4819-148-7-200804010-00020.
7
Studies of diabetes, thiazolidinediones, and coronary heart disease.
Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1313-4; author reply 1314-6. doi: 10.1002/pds.1498.
8
Cardiovascular risk and the thiazolidinediones: déjà vu all over again?
JAMA. 2007 Sep 12;298(10):1216-8. doi: 10.1001/jama.298.10.1216.
9
Rosiglitazone and pioglitazone. Beware fractures.
BMJ. 2009 Sep 29;339:b3957. doi: 10.1136/bmj.b3957.
10
Fracture risk is a class effect of glitazones.
BMJ. 2007 Mar 17;334(7593):551. doi: 10.1136/bmj.39154.373889.DB.
引用本文的文献
1
Risk Factors Associated with Bone Marrow Adiposity Deposition in Postmenopausal Women in the CASH China Study.
Diabetes Metab Syndr Obes. 2023 Apr 24;16:1167-1176. doi: 10.2147/DMSO.S401910. eCollection 2023.
本文引用的文献
1
Translational musculoskeletal science: is sarcopenia the next clinical target after osteoporosis?
Ann N Y Acad Sci. 2011 Nov;1237:95-105. doi: 10.1111/j.1749-6632.2011.06236.x.
2
Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism.
J Bone Miner Res. 2011 Sep;26(9):2012-25. doi: 10.1002/jbmr.417.
3
Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1.
J Biol Chem. 2011 Apr 8;286(14):12542-53. doi: 10.1074/jbc.M110.152405. Epub 2011 Feb 7.
4
Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition.
Cell. 2010 Jul 23;142(2):309-19. doi: 10.1016/j.cell.2010.06.002.
5
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism.
Cell. 2010 Jul 23;142(2):296-308. doi: 10.1016/j.cell.2010.06.003.
6
Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.
Osteoporos Int. 2011 Jan;22(1):187-94. doi: 10.1007/s00198-010-1184-7. Epub 2010 Feb 18.
7
Evidence for pleiotropic factors in genetics of the musculoskeletal system.
Bone. 2010 May;46(5):1226-37. doi: 10.1016/j.bone.2010.01.382. Epub 2010 Feb 10.
8
The response of bone to mechanical loading and disuse: fundamental principles and influences on osteoblast/osteocyte homeostasis.
Arch Biochem Biophys. 2008 May 15;473(2):117-23. doi: 10.1016/j.abb.2008.02.028. Epub 2008 Mar 4.
9
Lean mass and not fat mass is associated with male proximal femur strength.
J Bone Miner Res. 2008 Feb;23(2):189-98. doi: 10.1359/jbmr.071016.
10
Endocrine regulation of energy metabolism by the skeleton.
Cell. 2007 Aug 10;130(3):456-69. doi: 10.1016/j.cell.2007.05.047.
Zotero 插件